Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Alopecia areata involves immune response and gene changes affecting hair loss.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

Targeting Vδ1+T-cells may help treat alopecia areata.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

SOX10 in hair follicles is linked to inflammation in alopecia areata.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Mesenchymal Stem Cell therapy shows promise for treating hair loss in Alopecia Areata.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Female-pattern hair loss may involve an autoimmune-like process, suggesting new treatment options.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.